Related Experiment Video
Updated: Jun 7, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Na+ H+ exchanger-1: a link with atherogenesis?
Maria Sarigianni1, Apostolos Tsapas, Dimitri P Mikhailidis
1Aristotle University of Thessaloniki, Medical School, Metabolic Diseases Unit, Second Department of Internal Medicine, Greece.
The sodium/hydrogen exchanger-1 (NHE-1/SLC9A1) protein influences atherosclerosis development. Despite mixed clinical trial results for NHE-1 inhibitors, it remains a potential therapeutic target for preventing and treating this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Cell Physiology
Background:
- Sodium/hydrogen exchanger-1 (NHE-1/SLC9A1) is a key plasma membrane protein regulating intracellular pH and volume.
- NHE-1 has a known role in atherogenesis, but its clinical significance is not fully established.
Purpose of the Study:
- To review the contribution of NHE-1 to atherogenesis.
- To examine NHE-1's effects on endothelial cells, monocytes, smooth muscle cells, and platelets.
- To explore the relationship between NHE-1 and vascular risk factors.
Main Methods:
- Literature review of studies on NHE-1's role in atherogenesis.
- Analysis of NHE-1's involvement in monocyte functions related to atherosclerosis.
- Examination of correlations between NHE-1 and obesity, diabetes, hypertension, dyslipidemia, and inflammation.
Main Results:
- NHE-1 influences atherogenesis-related properties of isolated monocytes.
- NHE-1 is linked to key vascular risk factors including obesity, diabetes, hypertension, dyslipidemia, and inflammation.
Conclusions:
- NHE-1's role in atherosclerosis warrants further investigation.
- Despite past clinical trial outcomes, NHE-1 inhibitors may still hold potential for atherosclerosis treatment.
- NHE-1 represents a potential future therapeutic target for atherosclerosis prevention and management.
More Related Videos
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
11:51Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
Published on: February 3, 2018
Related Concept Videos
Atherosclerosis I: Introduction
Nitric Oxide Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Receptor-mediated Endocytosis